News
‘Ozempic face’: Accepting wrinkles for improved health
Some who are taking Ozempic are complaining about their faces thinning as an effect of this weight-loss drug. Dr. Anne Peters thinks the benefit...
Opinion
New studies change beliefs about cardiovascular disease
Why it doesn't matter if you take your antihypertensive agent in the morning or the evening explained.
Article
Updates on Glycemic Control in Type 2 Diabetes From EASD 2022
Updates on glycemic control for type 2 diabetes from EASD 2022 focus on ADA/EASD guidelines on hyperglycemia and results of a 44-year prospective...
Article
Advances in Insulin Therapy for Type 2 Diabetes From EASD 2022
From EASD 2022, Dr Anne L. Peters reports on the latest updates on insulin therapy for T2D,...
News
iLet system simplifies insulin delivery for type 1 diabetes
Dr Anne Peters offers perspective on how the iLet automated insulin system works and can improve management for patients with type 1 diabetes.
Opinion
Does COVID-19 raise the risk for diabetes?
Some data say yes and other data say no. Dr. Anne L. Peters sorts it out.
Opinion
What is the glycemic risk index and why do we need it?
Dr. Anne Peters discusses the development of the glycemic risk index, a new continuous glucose monitoring measure.
Opinion
Lifestyle changes can lead to remission, but not a cure, in type 2 diabetes
Lifestyle changes including healthy diet and increased exercise can lead to remission for patients with type 2 diabetes, allowing them to stop...